![]() |
|
|
Vol. 11, Issue 2, 721-734, February 2000
and
*Departments of Cell Biology and Biochemistry, *Lipid and
Lipoprotein Research Group, and Apolipoprotein B (apoB) is an essential component of chylomicrons,
very low density lipoproteins, and low density lipoproteins. ApoB is a
palmitoylated protein. To investigate the role of palmitoylation in
lipoprotein function, a palmitoylation site was mapped to Cys-1085 and
removed by mutagenesis. Secreted lipoprotein particles formed by
nonpalmitoylated apoB were smaller and denser and failed to assemble a
proper hydrophobic core. Indeed, the relative concentrations of
nonpolar lipids were three to four times lower in lipoprotein particles
containing mutant apoB compared with those containing wild-type apoB,
whereas levels of polar lipids isolated from wild-type or mutant apoB
lipoprotein particles appeared identical. Palmitoylation localized apoB
to large vesicular structures corresponding to a subcompartment of the
endoplasmic reticulum, where addition of neutral lipids was postulated
to occur. In contrast, nonpalmitoylated apoB was concentrated in a
dense perinuclear area corresponding to the Golgi compartment. The
involvement of palmitoylation as a structural requirement for proper
assembly of the hydrophobic core of the lipoprotein particle and its
intracellular sorting represent novel roles for this posttranslational modification.
Department of Medicine,
University of Alberta, Edmonton, Alberta T6G 2S2, Canada
This article has been cited by other articles:
![]() |
D. D. O. Martin, G. L. Vilas, J. A. Prescher, G. Rajaiah, J. R. Falck, C. R. Bertozzi, and L. G. Berthiaume Rapid detection, discovery, and identification of post-translationally myristoylated proteins during apoptosis using a bio-orthogonal azidomyristate analog FASEB J, March 1, 2008; 22(3): 797 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Vilas, M. M. Corvi, G. J. Plummer, A. M. Seime, G. R. Lambkin, and L. G. Berthiaume Posttranslational myristoylation of caspase-activated p21-activated protein kinase 2 (PAK2) potentiates late apoptotic events PNAS, April 25, 2006; 103(17): 6542 - 6547. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Morel, S. Demignot, D. Chateau, J. Chambaz, M. Rousset, and F. Delers Lipid-dependent Bidirectional Traffic of Apolipoprotein B in Polarized Enterocytes Mol. Biol. Cell, January 1, 2004; 15(1): 132 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Vukmirica, K. Tran, X. Liang, J. Shan, J. Yuan, B. A. Miskie, R. A. Hegele, M. D. Resh, and Z. Yao Assembly and Secretion of Very Low Density Lipoproteins Containing Apolipoprotein B48 in Transfected McA-RH7777 Cells. LACK OF EVIDENCE THAT PALMITOYLATION OF APOLIPOPROTEIN B48 IS REQUIRED FOR LIPOPROTEIN SECRETION J. Biol. Chem., April 11, 2003; 278(16): 14153 - 14161. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, V. Chauhan, A. T. Nguyen, J. Schultz, J. Davignon, S. G. Young, J. Boren, T. L. Innerarity, H. Rutai, and R. W. Milne Immunochemical evidence that human apoB differs when expressed in rodent versus human cells J. Lipid Res., March 1, 2003; 44(3): 547 - 553. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nunziante, S. Gilch, and H. M. Schatzl Essential Role of the Prion Protein N Terminus in Subcellular Trafficking and Half-life of Cellular Prion Protein J. Biol. Chem., January 31, 2003; 278(6): 3726 - 3734. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Vukmirica, T. Nishimaki-Mogami, K. Tran, J. Shan, R. S. McLeod, J. Yuan, and Z. Yao The N-linked oligosaccharides at the amino terminus of human apoB are important for the assembly and secretion of VLDL J. Lipid Res., September 1, 2002; 43(9): 1496 - 1507. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Fisher and H. N. Ginsberg Complexity in the Secretory Pathway: The Assembly and Secretion of Apolipoprotein B-containing Lipoproteins J. Biol. Chem., May 10, 2002; 277(20): 17377 - 17380. [Full Text] [PDF] |
||||
![]() |
E. A. Fisher, M. Pan, X. Chen, X. Wu, H. Wang, H. Jamil, J. D. Sparks, and K. J. Williams The Triple Threat to Nascent Apolipoprotein B. EVIDENCE FOR MULTIPLE, DISTINCT DEGRADATIVE PATHWAYS J. Biol. Chem., July 20, 2001; 276(30): 27855 - 27863. [Abstract] [Full Text] [PDF] |
||||